i10 Productivity
Rankings
Pfizer Inc. ScientistsOthers i10 Productivity Rankings 2024
Productivity Rankings is a unique service offered only by “AD Scientific Index”. This is a ranking system derived from the i10 index in order to show the productivity of the scientist in publishing scientific articles of value. Productivity Rankings is an instrument that lists productive scientists in a given area, discipline, university, and country and can guide the development of meaningful incentives and academic policies. The world rankings, regional rankings, and university rankings of scientists in this table are developed based on the total i10 index. Click for "last 6 years' i10 index". Also see: Universities Rankings 2024 (Sort by : Total i10 Index) and Universities Rankings 2024 (Sort by : Last 6 Years i10 Index)
| Total i10 Index | AD Scientific Index - World Scientists i10 Productivity Rankings - 2024 | i10 Index Metrics | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| University Rank | Country Rank | Region Rank | World Rank | Name | Country | University / Institution |
Subject Research Areas |
Total | Last 6 Year | Last 6 year/total |
| 446 | 306,370 | 342,117 | 1,236,413 |
United States |
Pfizer Inc.
|
Others
bioinformática | genómica. | |
4 | 4 | 1.000 | |
| 447 | 309,106 | 345,183 | 1,249,636 |
United States |
Pfizer Inc.
|
Others
|
4 | 4 | 1.000 | |
| 448 | 309,239 | 345,328 | 1,250,035 |
United States |
Pfizer Inc.
|
Others
Chemical Biology | Drug Discovery | Ligand-Target Deconvolution | Quantitative Proteomics | Oncology | |
4 | 4 | 1.000 | |
| 449 | 310,336 | 346,565 | 1,254,526 |
United States |
Pfizer Inc.
|
Others
Multiscale modeling | computational biophysics | pharmacometrics | systems pharmacology | |
4 | 4 | 1.000 | |
| 450 | 310,705 | 346,987 | 1,256,085 |
United States |
Pfizer Inc.
|
Others
|
4 | 4 | 1.000 | |
| 456 | 313,433 | 350,012 | 1,272,006 |
United States |
Pfizer Inc.
|
Others
|
4 | 3 | 0.750 | |
| 457 | 314,841 | 351,596 | 1,278,787 |
United States |
Pfizer Inc.
|
Others
inflammation and immunology | neuroscience | |
4 | 2 | 0.500 | |
| 458 | 315,516 | 352,347 | 1,284,409 |
United States |
Pfizer Inc.
|
Others
Synthetic Chemistry. Vaccine Research and Development. | |
4 | 2 | 0.500 | |
| 462 | 317,555 | 354,636 | 1,296,226 |
United States |
Pfizer Inc.
|
Others
|
4 | 1 | 0.250 | |
| 466 | 323,944 | 361,767 | 1,335,979 |
United States |
Pfizer Inc.
|
Others
Water Treatment | |
3 | 3 | 1.000 | |
|
Click for INSTITUTIONAL BULK REGISTRATION and PREMIUM MEMBERSHIP advantages |
|
||||||||
| 467 | 324,648 | 362,565 | 1,339,098 |
United States |
Pfizer Inc.
|
Others
PKPD | evolutionary biology | |
3 | 3 | 1.000 | |
| 467 | 324,648 | 362,565 | 1,339,098 |
United States |
Pfizer Inc.
|
Others
|
3 | 3 | 1.000 | |
| 471 | 325,731 | 363,790 | 1,344,356 |
United States |
Pfizer Inc.
|
Others
|
3 | 3 | 1.000 | |
| 473 | 326,644 | 364,811 | 1,348,761 |
United States |
Pfizer Inc.
|
Others
|
3 | 3 | 1.000 | |
| 474 | 328,783 | 367,190 | 1,358,789 |
United States |
Pfizer Inc.
|
Others
|
3 | 3 | 1.000 | |
| 475 | 328,877 | 367,291 | 1,359,153 |
United States |
Pfizer Inc.
|
Others
|
3 | 3 | 1.000 | |
| 482 | 342,720 | 382,813 | 1,447,668 |
United States |
Pfizer Inc.
|
Others
Patient Preference | Threshold Technique | DCE | BWS | |
2 | 2 | 1.000 | |
| 484 | 347,362 | 388,002 | 1,474,370 |
United States |
Pfizer Inc.
|
Others
|
2 | 2 | 1.000 | |
| 485 | 352,436 | 393,716 | 1,499,622 |
United States |
Pfizer Inc.
|
Others
|
2 | 2 | 1.000 | |
| 487 | 356,631 | 398,406 | 1,517,779 |
United States |
Pfizer Inc.
|
Others
Spectroscopy | Chemometrics | Integrated analytics | Process Analytical Technology | |
2 | 2 | 1.000 | |
| 489 | 363,559 | 406,204 | 1,567,477 |
United States |
Pfizer Inc.
|
Others
Fluid Mechanics | Microencapsulation | Mathematical Modeling | CFD | Soft matter | |
2 | 0 | 0.000 | |
| 491 | 368,814 | 412,011 | 1,610,312 |
United States |
Pfizer Inc.
|
Others
|
1 | 1 | 1.000 | |
| 493 | 371,860 | 415,419 | 1,629,859 |
United States |
Pfizer Inc.
|
Others
Targeted Drug Delivery | Cancer | Allergies | Antibody Purification | Bioconjugation | |
1 | 1 | 1.000 | |
| 496 | 377,512 | 421,816 | 1,668,428 |
United States |
Pfizer Inc.
|
Others
Assay development | c. difficile | diagnostic assay | |
1 | 1 | 1.000 | |
| 497 | 378,956 | 423,429 | 1,675,262 |
United States |
Pfizer Inc.
|
Others
Biotechnology | Immunology | |
1 | 1 | 1.000 | |